These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265 [TBL] [Abstract][Full Text] [Related]
9. Studies in vitro with ICI 174,864, [D-Pen2, D-Pen5]-enkephalin (DPDPE) and [D-Ala2, NMePhe4, Gly-ol]-enkephalin (DAGO). Hirning LD; Mosberg HI; Hurst R; Hruby VJ; Burks TF; Porreca F Neuropeptides; 1985 Feb; 5(4-6):383-6. PubMed ID: 2987739 [TBL] [Abstract][Full Text] [Related]
10. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse. Vaught JL; Mathiasen JR; Raffa RB J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533 [TBL] [Abstract][Full Text] [Related]
11. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
12. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214 [TBL] [Abstract][Full Text] [Related]
13. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice. Heyman JS; Mulvaney SA; Mosberg HI; Porreca F Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970 [TBL] [Abstract][Full Text] [Related]
14. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. Rady JJ; Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the receptor binding profile of (3H)-dermorphin in the rat brain. Amiche M; Sagan S; Mor A; Delfour A; Nicolas P Int J Pept Protein Res; 1988 Dec; 32(6):506-11. PubMed ID: 2907751 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain. Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574 [TBL] [Abstract][Full Text] [Related]
17. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats. Sbacchi M; La Regina A; Petrillo P; Tavani A NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999 [TBL] [Abstract][Full Text] [Related]
18. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats. Hoffman DC; West TE; Wise RA Brain Res; 1991 Jun; 550(2):205-12. PubMed ID: 1653084 [TBL] [Abstract][Full Text] [Related]
19. Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin. Heyman JS; Vaught JL; Mosberg HI; Haaseth RC; Porreca F Eur J Pharmacol; 1989 Jun; 165(1):1-10. PubMed ID: 2548877 [TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant effects of mu (DAGO) and delta (DPDPE) enkephalins in rats. Tortella FC; Echevarria E; Robles L; Mosberg HI; Holaday JW Peptides; 1988; 9(5):1177-81. PubMed ID: 2854247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]